2 Researchers are still studying the mechanism and effects of GLP-1 drugs in other tissues where the GLP-1 receptor is expressed, including the brain, heart, and immune system
Their effects on the coagulation system, potential interactions, side effects, and warning signs of excessive bleeding underscore the need for moderation and careful medical supervision, especially for individuals taking blood-thinning drugs
Thus, their concentrations in lipid-containing products should be reduced [87]
Schedule: Daily subcutaneous injections for 20 consecutive days, followed by 46 months off-cycle
Compared with older pharmacologic options, GLP-1 receptor agonists and newer incretin-based therapies generally offer greater average weight reduction, but they also raise specific issues related to gastrointestinal tolerability, long-term continuation, affordability, and access ( 6 Safety and practical prescribing considerations in KOA patients Safety considerations are particularly important when GLP-1 receptor agonists are considered for patients with obesity-related KOA, because this population often includes older adults, patients with multimorbidity, and individuals approaching elective arthroplasty
